North America Endoscopic Retrograde Cholangiopancreatography Devices Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2021 –2028 |
 시장 규모(기준 연도) |
USD 767.59 Million |
 시장 규모(예측 연도) |
USD 1,179.01 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
>북미 내시경 역행성 담관췌관조영술 장치 시장, 제품 유형(내시경 치료 장치, 내시경, 영상 장치 등), 방식(단일 사용, 독립형, 핸드헬드), 시술(담관 절제술, 담관 스텐트 삽입, 담관 확장술, 췌장관 스텐트 삽입, 췌장 괄약근 절제술), 적용 분야(담관, 췌장, 담낭, 간 등), 최종 사용자(병원, 외래 수술 센터 , 진단 실험실 등), 시설 유형(대형, 중형, 소형), 유통 채널(직접 입찰, 제3자 유통, 소매 판매), 국가(미국, 캐나다, 멕시코) 산업 동향 및 예측 2028.
시장 분석 및 통찰력: 북미 내시경 역행성 담관췌관조영술 장비 시장
북미 내시경 역행성 담관췌관조영술 장치 시장은 2021년부터 2028년까지의 예측 기간 동안 성장할 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 6.0%의 CAGR로 성장하고 있으며 2020년의 7억 6,759만 달러에서 2028년까지 1,179.01만 달러에 도달할 것으로 예상된다고 분석했습니다. 췌장 및 담관 질환의 높은 유병률은 예측 기간 동안 시장 수요를 촉진하는 주요 동인이 될 가능성이 높습니다.
췌장 및 담관 질환의 높은 유병률, 시장에 많은 플레이어가 존재하고 첨단 기술 기반 장치가 개발되어 시장이 성장하고 있습니다. FDA가 설정한 엄격한 규제 시나리오는 시장에 제약으로 작용하고 있습니다. 첨단 의료 인프라, 유리한 환불 시나리오는 시장에 기회로 작용하고 있습니다. 그러나 숙련된 인력의 부족은 시장 성장에 도전이 될 수 있습니다.
북미 내시경 역행성 담관췌관조영술 장치 시장 보고서는 시장 점유율, 새로운 개발 및 국내 및 지역 시장 참여자의 영향에 대한 세부 정보를 제공하고, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서 기회를 분석합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 당사에 문의하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.
북미 내시경 역행성 담관췌관조영술 장비 시장 범위 및 시장 규모
북미 내시경 역행성 담관췌관조영술 장치 시장은 제품 유형, 양식, 시술, 응용 프로그램, 최종 사용자, 시설 유형 및 유통 채널을 기반으로 하는 7개의 주요 세그먼트로 분류됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
- On the basis of product type, the North America endoscopic retrograde cholangiopancreatography devices market is segmented into endotherapy devices, endoscopes, imaging devices, and others. In 2021, the endotherapy devices segment is expected to dominate the market due to various types of equipment, and big players are manufacturing this equipment in the North American market.
- On the basis of modality, the North America endoscopic retrograde cholangiopancreatography devices market is segmented into single-use, standalone, and handheld. In 2021, the single-use segment is expected to dominate the market because there is no risk of disease transmission from one patient to another while using single-use devices.
- On the basis of procedure, the North America endoscopic retrograde cholangiopancreatography devices market is segmented into biliary sphincterotomy, biliary stenting, biliary dilation, pancreatic duct stenting, and pancreatic sphincterotomy. In 2021, the biliary sphincterotomy segment is expected to dominate the market because of the high prevalence of pancreatic tumors in the North American region.
- On the basis of application, the North America endoscopic retrograde cholangiopancreatography devices market is segmented into the bile duct, pancreas, gall bladder, liver, and others. In 2021, the bile duct segment is expected to dominate the market because of the high prevalence of biliary diseases in the North American region.
- On the basis of end user, the North America endoscopic retrograde cholangiopancreatography devices market is segmented into hospitals, ambulatory surgical centers, diagnostic laboratories, and others. In 2021, the hospital's segment is expected to dominate the market due to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by medical device companies to expand their capabilities in the ERCP market.
- On the basis of facility type, the North America endoscopic retrograde cholangiopancreatography devices market is segmented into large, medium, and small. In 2021, the large segment is expected to dominate the market due to the high demand for ERCP procedures in North America.
- On the basis of distribution channel, the North America endoscopic retrograde cholangiopancreatography devices market is segmented into direct tenders, third-party distribution, and retail sales. In 2021, the direct tender segment is expected to dominate the market because of significant growth due to the overall control over sales and revenue processes and direct interactions with customers.
North America Endoscopic Retrograde Cholangiopancreatography Devices Market Country Level Analysis
The North America endoscopic retrograde cholangiopancreatography devices market is analyzed, and market size information is provided by country, product type, modality, procedure, applications, end-user, facility type, and distribution channel.
The countries covered in the North America endoscopic retrograde cholangiopancreatography devices market report are the U.S., Canada, and Mexico.
North America is expected to dominate the market as in the North American countries; the demand for ERCP devices is increasing rapidly with increasing healthcare infrastructure. The U.S. is expected to dominate in the North American market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North American brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
The Presence of Advanced Technology and Strategic Initiatives Taken by Players are Creating New Opportunities in the North America Endoscopic Retrograde Cholangiopancreatography Devices Market
North America endoscopic retrograde cholangiopancreatography devices market also provides you with detailed market analysis for every country's growth in a particular industry with ERCP products sales, the impact of advancement in the market, and changes in regulatory scenarios with their support for the market. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Europe Endoscopic Retrograde Cholangiopancreatography Devices Market Share Analysis
North America endoscopic retrograde cholangiopancreatography devices market competitive landscape provide details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company's focus on the endoscopic retrograde cholangiopancreatography devices market.
The major companies providing the North America endoscopic retrograde cholangiopancreatography devices are Olympus Corporation, Boston Scientific Corporation, Medtronic, BD, Ambu Inc., CONMED Corporation, HOBBS MEDICAL, INC., FUJIFILM Corporation, TeleMed Systems, Inc., Merit Medical Systems, Cook, KARL STORZ SE & Co. KG, Johnson & Johnson Services, Inc., HOYA Corporation, STERIS, Shaili Endoscopy, among others.
DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
시장 참여자들의 전략적 이니셔티브와 내시경 역행성 담관췌관조영술 장치에 대한 새로운 기술적 발전은 다양한 치료법에 대한 격차를 메우고 있습니다.
예를 들어,
- 2020년 7월, Ambu Inc.는 멸균 일회용 십이지장경인 Ambu aScope Duodeno에 대한 FDA 승인을 받았다고 발표했습니다. 이를 통해 회사는 향후 몇 년 동안 사업을 확장하는 데 도움이 되었습니다.
- 2021년 1월, CONMED Corporation은 JP Morgan Virtual Healthcare Conference에서 발표합니다. 이 컨퍼런스는 고객에게 제품에 대한 올바른 지식을 제공하는 것을 목표로 했습니다. 이 컨퍼런스는 시장 성장을 촉진하고 수익 창출에 도움이 되었습니다.
시장 참여자들의 협력, 합작투자 및 기타 전략은 내시경 역행성 담관췌관조영술 장비 시장에서 회사 시장을 확대하고 있으며, 이를 통해 조직이 시장에 제공하는 제품을 개선하는 데에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEAR CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGIONAL SUMMARY
5.1 NORTH AMERICA
5.2 EUROPE
5.3 ASIA-PACIFIC
5.4 SOUTH AMERICA
5.5 MIDDLE EAST AND AFRICA
6 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGULATIONS
6.1 UNITED STATES
6.2 EUROPE
6.3 CHINA
6.4 AUSTRALIA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 SURGE IN PREVALENCE OF PANCREATIC AND LIVER DISORDERS
7.1.2 INCREASE IN THE GERIATRIC POPULATION
7.1.3 RISING HEALTHCARE EXPENDITURE
7.1.4 HIGH PREVALENCE OF PANCREATIC CANCER
7.2 RESTRAINTS
7.2.1 HIGH COST OF DEVICES
7.2.2 STRINGENT GOVERNMENT RULES
7.2.3 EMERGENCE OF COVID-19
7.3 OPPORTUNITIES
7.3.1 STRATEGIC INITIATIVES TAKEN BY PLAYERS
7.3.2 RISE IN ALCOHOL CONSUMPTION AND SURGE IN SMOKING
7.3.3 RISING DISPOSABLE INCOME
7.3.4 GROWING MEDICAL TOURISM
7.4 CHALLENGES
7.4.1 COMPLICATIONS ASSOCIATED WITH PROCEDURE
7.4.2 SHORTAGE OF SKILLED PERSONNEL
8 IMPACT OF COVID-19 ON NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY
8.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID 19
8.5 CONCLUSION:
9 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 ENDOTHERAPY DEVICES
9.2.1 SPHINCTEROTOME
9.2.2 CANNULAS
9.2.3 CATHETERS
9.2.4 BALLOONS
9.2.5 LITHOTRIPTERS
9.2.6 STENTS
9.2.7 GUIDING WIRES
9.2.8 FORCEPS
9.2.9 BASKETS
9.2.10 SNARES
9.2.11 OTHERS
9.3 ENDOSCOPE
9.4 IMAGING DEVICES
9.5 OTHERS
10 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY
10.1 OVERVIEW
10.2 SINGLE USE
10.3 STANDALONE
10.4 HANDHELD
11 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE
11.1 OVERVIEW
11.2 BILIARY SPHINCTERECTOMY
11.3 BILIARY STENTING
11.4 BILIARY DILATION
11.5 PANCREATIC DUCT STENTING
11.6 PANCREATIC DUCT DILATION
11.7 PANCREATIC SPHINCTERECTOMY
12 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 BILE DUCT
12.3 PANCREAS
12.4 GALL BLADDER
12.5 LIVER
12.6 OTHERS
13 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 AMBULATORY SURGICAL CENTERS
13.4 DIAGNOSTIC LABORATORIES
13.5 OTHERS
14 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE
14.1 OVERVIEW
14.2 LARGE
14.3 MEDIUM
14.4 SMALL
15 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDERS
15.3 THIRD PARTY DISTRIBUTION
15.4 RETAIL SALES
16 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION
16.1 NORTH AMERICA
16.1.1 U.S.
16.1.2 CANADA
16.1.3 MEXICO
17 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 OLYMPUS CORPORATION
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 BOSTON SCIENTIFIC CORPORATION
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 STERIS
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 FUJIFILM CORPORATION
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENTS
19.5 BD
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENTS
19.6 MEDTRONIC
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 JOHNSON & JOHNSON SERVICES, INC.
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT DEVELOPMENTS
19.8 AMBU INC.
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENTS
19.9 CONMED CORPORATION
19.9.1 COMPANY SNAPSHOT
19.9.2 REVENUE ANALYSIS
19.9.3 PRODUCT PORTFOLIO
19.9.4 RECENT DEVELOPMENTS
19.1 COOK
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENT
19.11 HOBBS MEDICAL INC.
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 HOSPILINE EQUIPMENTS
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT DEVELOPMENT
19.13 HOYA CORPORATION
19.13.1 COMPANY SNAPSHOT
19.13.2 REVENUE ANALYSIS
19.13.3 PRODUCT PORTFOLIO
19.13.4 RECENT DEVELOPMENT
19.14 KARL STORZ SE & CO. KG
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENTS
19.15 MEDI-GLOBE GMBH
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
19.16 MERIT MEDICAL SYSTEMS
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENT
19.17 SHAILI ENDOSCOPY
19.17.1 COMPANY SNAPSHOT
19.17.2 PRODUCT PORTFOLIO
19.17.3 RECENT DEVELOPMENT
19.18 TELEMED SYSTEMS, INC.
19.18.1 COMPANY SNAPSHOT
19.18.2 PRODUCT PORTFOLIO
19.18.3 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
표 목록
TABLE 1 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA ENDOSCOPE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA IMAGING DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA SINGLE USE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA STANDALONE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA HANDHELD IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA BILIARY SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA BILIARY STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA BILIARY DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA PANCREATIC DUCT STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA PANCREATIC DUCT DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA PANCREATIC SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA BILE DUCT IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA PANCREAS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA GALL BLADDER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA LIVER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA HOSPITALS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA DIAGNOSTIC LABORATORIES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA LARGE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA MEDIUM IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA SMALL IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA DIRECT TENDERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA THIRD PARTY DISTRIBUTION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA RETAIL SALES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 46 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 47 U.S. ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 49 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 50 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 53 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 55 CANADA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 57 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 58 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 61 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 62 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 63 MEXICO ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 65 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 66 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 69 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
그림 목록
FIGURE 1 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION
FIGURE 11 THE HIGH PREVALENCE OF PANCREATIC AND BILIARY DISEASES IS EXPECTED TO DRIVE THE NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ENDOTHERAPY DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET
FIGURE 14 PANCREATIC CANCER MORTALITY, BY REGION (2020)
FIGURE 15 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2020
FIGURE 16 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 17 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 18 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2020
FIGURE 20 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2021-2028 (USD MILLION)
FIGURE 21 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, CAGR (2021-2028)
FIGURE 22 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 23 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2020
FIGURE 24 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2021-2028 (USD MILLION)
FIGURE 25 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)
FIGURE 26 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2020
FIGURE 28 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 29 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 30 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2020
FIGURE 32 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 33 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, CAGR (2021-2028)
FIGURE 34 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2020
FIGURE 36 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2021-2028 (USD MILLION)
FIGURE 37 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, CAGR (2021-2028)
FIGURE 38 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, LIFELINE CURVE
FIGURE 39 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 40 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 41 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 42 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SNAPSHOT (2020)
FIGURE 44 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020)
FIGURE 45 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 46 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 47 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 48 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
